Clinical trial
A Prospective, Multicenter, Single Arm, Post-Approval Study of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females
NCT02813577 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single Arm, Post-Approval Study of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females
- Lead sponsor
- C. R. Bard
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 20, 2018
- Completion date
- February 18, 2019
- Enrollment
- 4 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
femoral artery occlusion, femoral artery stenosis, popliteal artery occlusion, popliteal artery stenosis